ClinicalTrials.gg
RecruitingNCT06687304LISUpdated Dec 2, 2025

Light in Healthcare Environment (Ljus i sjukhusmiljö)

An interventional study of Light enhancement in Sleep Quality, Well-being and Melatonin, sponsored by Lund University. Recruiting at 3 sites in Sweden. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-02.

Sponsored by Lund University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Nov 2024; still recruiting 2 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Non-randomized
Ages
21 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 58 studies in Sleep Initiation and Maintenance Disorders with a site in Sweden — 13 open to participants now, 15 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · Sweden.

Planned enrollment
50th of 54
18 · median 105
Started
2024
with 3 others
No phase
42 of 58
11 open now
Primary completion
2027-03
later than 8 of 14 live
Registered
53rd of 58
by date

Among the 58 studies in Sleep Initiation and Maintenance Disorders with a site in Sweden, this one is the 50th largest by planned enrollment of the 54 interventional ones that give a count, is one of 4 that started in 2024, is one of 42 with no phase, reaches primary completion later than 8 of the 14 other live ones, and was the 53rd registered.

Sleep Initiation and Maintenance Disorders

2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.

Browse Sleep Initiation and Maintenance Disorders studies →

Open to participants now

13 of the 58 studies in Sleep Initiation and Maintenance Disorders with a site in Sweden are open now. Recruiting first, the newest first:

7 more — sign in →

All 13 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.

This study: 21 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 58 studies in Sleep Initiation and Maintenance Disorders with a site in Sweden, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn if light can enhance the feeling of well-being and sleep quality in Radiographers. It will also find out if there is an optimal recipe for light. The main questions it aims to answer are:

  • Will alertness, energy levels, and sleep quality increase in radiographers when the lighting is differed?
  • What light recipe is the most beneficial for the personnel? Researchers will compare no enhanced light environment to different enhanced light environment to see if the enhanced light is beneficial for radiographers.

Participants will:

  • Will work in an enhanced light environment or a non-enhanced light environment
  • Answer surveys
  • Take saliva sample
Read the detailed description

The aim of this study is to examine the impact of different daylight lighting conditions in the radiographer's workplace environment. Will alertness, energy levels, well-being, and sleep quality increase in the personnel at the radiology department when the lighting is differed? Which light recipe is the most beneficial for the personnel at the radiology department? Method Design: In order to ascertain the light level that yields the desired effect, an quasi-experimental study design will be employed to identify the optimal light recipe with the appropriate light intensity. A crossover design is intended for implementation. This design approach offers the advantage of having each participant serve as their own control, thereby minimizing the potential impact of inter-group differences on the results. Furthermore, it enhances statistical efficiency, even with a reduced number of study participants (Lim \& In, 2021).

Context/recruitment: Recruitments of personnel from various radiology departments at Skåne University Hospital (SUS) in Lund are planned to be conducted. A total of 18 the personnel at the radiology department will be included during the darker months of the year. At 10 to 20 workstations, a floor lamp equipped with an adjusted light prescription will be installed. Participants will be assigned to conditions in which the lamp will either be activated with the specified light recipe or remain turned off. After a duration of two weeks, the conditions will be reversed for an additional two-week period. This process will be repeated using four different light recipes to evaluate their effects on the energy levels, activity, and sleep quality of the staff. The objective is to gather insights from each season that can be implemented in the subsequent winter to determine the optimal light level.

Data collection: Subjective Measurement Methods - Staff Surveys

General Survey Participants will be asked questions regarding their typical age and gender. Additionally, a modified version of the Morningness-Eveningness Questionnaire (MEQ) will be utilized to determine each individual;s chronotype (Adan \& Almirall, 1991). A Swedish translation of this questionnaire has proven effective in assessing chronotype and is appropriate for use when a shorter assessment tool is needed (Danielsson et al., 2019).

Karolinska Sleepiness Scale (KSS) To assess the level of alertness and energy among study participants, the KSS will be utilized. This scale employs a 9-point Likert format to evaluate perceived fatigue and energy levels (Åkerstedt \& Gillberg, 1990). The KSS has been utilized in various research studies to examine the impact of lighting conditions on perceived alertness.

Patient-Reported Outcomes Information System Short Form Sleep Disturbance 8a(PROMIS) The Patient-Reported Outcomes Measurement Information System (PROMIS) is an assessment tool designed to measure self-reported sleep disturbances, including sleep quality, difficulty falling asleep, and staying asleep. It consists of 8 items rated by patients to evaluate the frequency and severity of sleep issues, supporting clinical insights into sleep-related health impacts.

Furthermore, participants \& well-being will be quantified utilizing the WHO-5 Well-Being Index.

Objective Measurement Methods: Sleep Data via Activity Bands - Actiwatch

The employment of activity monitors allows for the objective measurement of sleep. The actigraphy device is worn on the non-dominant wrist and is non-invasive (Weiss et al., 2010). It continuously tracks the participant's movements and records sleep parameters including duration and quality. These measurements can subsequently be analyzed (Ancoli-Israel et al., 2015). Due to the impracticality of wearing these wristbands during working hours, participants will attach them to their clothing at work and wear them on their wrist after work hours.

Additionally, saliva samples will be collected to measure cortisol and melatonin levels in the study participants. Cortisol secretion is stimulated by dawn light or, in winter, often by office lighting. This secretion level provides an objective parameter for assessing activation. Conversely, melatonin secretion is suppressed by the light of dawn, and the extent of this inhibition serves as an indicator of the lights effectiveness.

03

Conditions studied

  • Sleep Quality
  • Well-being
  • Melatonin
  • Cortisol
  • Energy Levels

Keywords

  • Light
  • Radiography
  • Light environment
  • Circadian rhythm
  • Personnel at radiology departments
04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Radiographer

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
18 participants (estimated)

Study arms

  • Active comparator
    Enhanced light environment

    Device: Light enhancement

  • No intervention
    Non-enhanced light environment

Interventions

  • DeviceLight enhancement

    Light recipe that mimics the varying daylight of the day

    Also known as: Lamp, Light recipe, Dynamic lighting

06

What researchers measure

Primary outcomes

  1. Karolinska Sleepiness Scale (KSS)

    To assess the subjective level of sleepiness at a particular time during the day

    Time frame: Measurements will be taken three times daily over a period of 16 to 20 weeks, depending on the start date of the inclusion phase, for each period.

  2. WHO-5 Well-Being Index

    To assess the level of well-being, the WHO-5 Well-Being Index is used. It's a brief, self-reported measure of current mental well-being, consisting of five questions that assess positive mood, vitality, and general interest over the past two weeks.

    Time frame: Measurements will be taken at the start and then second Friday in each two-week period over the 16 to 20 weeks (depending on when the inclusion phase can begin) during which inclusion occurs for each season.

  3. PROMIS

    Patient-Reported Outcomes Measurement Information System (PROMIS) is a standardized, self-reported questionnaire designed to measure an individual's perception of their sleep quality, specifically addressing issues like difficulty falling asleep, staying asleep, and feelings of restlessness. It consists of 8 items that gauge the severity of sleep disturbances over the past seven days.

    Time frame: Measurements will be taken at the start and then every Friday in each two-week period over the 16 to 20 weeks (depending on when the inclusion phase can begin) during which inclusion occurs for each season.

Other outcomes

  1. Melatonin

    Melatonin levels will be measured through saliva samples throughout the day to assess the variations in melatonin.

    Time frame: Measurements will be taken on Mondays, Wednesdays, and Fridays each week over the 16 to 20 weeks (depending on when the inclusion phase can begin) during which inclusion takes place for each season.

  2. Cortisol

    Cortisol levels will be measured through saliva samples throughout the day to assess variations in cortisol values, allowing us to observe, e.g, variations in stress responses.

    Time frame: Measurements will be taken on Mondays, Wednesdays, and Fridays each week over the 16 to 20 weeks (depending on when the inclusion phase can begin) during which inclusion takes place for each season.

07

Study locations

3 of 3 sites recruiting
08

References and documents

Publications

  • Weiss AR, Johnson NL, Berger NA, Redline S. Validity of activity-based devices to estimate sleep. J Clin Sleep Med. 2010 Aug 15;6(4):336-42. PubMed 20726281 ↗
  • Ancoli-Israel S, Martin JL, Blackwell T, Buenaver L, Liu L, Meltzer LJ, Sadeh A, Spira AP, Taylor DJ. The SBSM Guide to Actigraphy Monitoring: Clinical and Research Applications. Behav Sleep Med. 2015;13 Suppl 1:S4-S38. doi: 10.1080/15402002.2015.1046356. No abstract available. PubMed 26273913 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Mar 2027, 28 months after the start.

Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's planned 28 months is above that.

Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 4, 2024
First posted
Nov 13, 2024
StartActual
Nov 15, 2024
Primary completionEst.
Mar 31, 2027
CompletionEst.
Mar 31, 2027
Last update
Dec 2, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06687304
Lead sponsor
Lund University
Collaborators
AFA Insurance
Responsible party
Sponsor
First posted
Nov 13, 2024
Start date
Nov 15, 2024
Primary completion
Mar 31, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Dec 2, 2025

Study contacts

Pether Jildenstal, PhD
Contact
pether.jildenstal@med.lu.se
0046462220000

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion